A Message From the Moderator
non small cell lung cancer
Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors
non small cell lung cancer
Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer
non small cell lung cancer
Microwave ablation for subpleural stage I nonsmall cell lung cancer: a prospective, single-center study comparing three anesthesia models
non small cell lung cancer
Iron overload enhances the susceptibility to cysteine deprivation-induced ferroptosis in non-small cell lung cancer cells
non small cell lung cancer
Relationship of immune response with intestinal flora and metabolic reprogramming in patients with non-small cell lung cancer
non small cell lung cancer
Association Between Social Vulnerability Index and Time-to-Treatment in Resectable Non-Small Cell Lung Cancer
non small cell lung cancer
Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer
non small cell lung cancer
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer
non small cell lung cancer
Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer: outcomes by tumor mutational burden in POSEIDON
non small cell lung cancer
Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation
non small cell lung cancer
Therapeutic efficacy of TMTP1-modified EVs in overcoming bone metastasis and immune resistance in PIK3CA mutant NSCLC
non small cell lung cancer
Real-World Clinical Characteristics, Treatment Patterns, and Clinical Outcomes in US Patients with Stage I–III Resected NSCLC Without Known EGFR Mutations: The RESECT Study | Drugs
non small cell lung cancer
New advances in the treatment of EGFR exon20ins mutant advanced NSCLC
non small cell lung cancer
The expression of circSATB2, PEAK1 in non-small cell lung cancer tissue and their relationships with clinical pathological characteristics, as well as postoperative recurrence and metastasis
non small cell lung cancer
Prediction of Occult Lymph Node Metastasis in cN0 Stage Non-Small Cell Lung Cancer Using Contrast-Enhanced CT
non small cell lung cancer
Quality of complex care in the Netherlands
non small cell lung cancer
Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement
non small cell lung cancer
Splenic index score as a predictor of outcomes in metastatic non small cell lung cancer patients treated with immune checkpoint inhibitors
non small cell lung cancer
Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
non small cell lung cancer
The role of bone radiotherapy during immune checkpoint inhibitors treatment of non-small-cell lung cancer: a single-institution experience
non small cell lung cancer
The value of HE4 and its combined detection on predicting recurrence and cancer death in patients with non–small cell lung cancer
non small cell lung cancer
Multimodal Doctor-in-the-Loop: A Clinically-Guided Explainable Framework for Predicting Pathological Response in Non-Small Cell Lung Cancer
non small cell lung cancer
Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations
non small cell lung cancer
Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50%
non small cell lung cancer
